These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11979070)

  • 1. Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosis.
    Feinmesser M; Schachter JM; Tobar A; Sulkes J; Gutman H; Kruk N; Okon E
    Am J Dermatopathol; 2002 Apr; 24(2):108-17. PubMed ID: 11979070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of elastin immunostain improves the evaluation of melanomas associated with nevi.
    Kamino H; Tam S; Tapia B; Toussaint S
    J Cutan Pathol; 2009 Aug; 36(8):845-52. PubMed ID: 19032378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
    Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
    J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
    Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
    Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
    Roncati L; Pusiol T; Piscioli F
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in thin cutaneous malignant melanoma.
    Månsson-Brahme E; Carstensen J; Erhardt K; Lagerlöf B; Ringborg U; Rutqvist LE
    Cancer; 1994 May; 73(9):2324-32. PubMed ID: 8168037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E; Vizoso F; Martín A; Quintela I; Corte MD; Seguí ME; Ordiz I; Merino AM
    J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
    Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
    Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
    Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
    Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein.
    Ntayi C; Labrousse AL; Debret R; Birembaut P; Bellon G; Antonicelli F; Hornebeck W; Bernard P
    J Invest Dermatol; 2004 Feb; 122(2):256-65. PubMed ID: 15009703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant melanoma: depth of invasion and histologic typing].
    Hermanek P; Hornstein OP; Tonak J; Weidner F
    Beitr Pathol; 1976 May; 157(3):269-82. PubMed ID: 1275868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does palpability of primary cutaneous melanoma predict dermal invasion?
    O'Donnell BF; Marsden JR; O'Donnell CA; Sanders DS; Billingham C
    J Am Acad Dermatol; 1996 Apr; 34(4):632-7. PubMed ID: 8601653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.